Stock listing

YPH Stock Price, News, Filings & Events — Astellas Pharma Inc.

Selected listing: YPH · GETTEX · EUR · DE

The YPH:GETTEX listing represents Astellas Pharma Inc., a global pharmaceutical company focused on innovative medicines in areas such as oncology, urology, and immunology. Recently, the company has been active in advancing its pipeline and has made announcements regarding new clinical trials and partnerships. Investors can find the latest news, regulatory filings, and upcoming events related to Astellas Pharma on this page, providing valuable insights into its market position and strategic direction. The context of the pharmaceutical industry and ongoing developments may influence Astellas' performance and investor interest.

YPH:GETTEXEURDEUpdated August 1, 2026
Astellas Pharma Inc. logo
Ticker
YPH:GETTEX
Asset type
Stock
Market cap
$25.79B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GETTEX
Currency
EUR

Astellas Pharma Inc. YPH:GETTEX stock context

The YPH:GETTEX listing represents Astellas Pharma Inc., a global pharmaceutical company focused on innovative medicines in areas such as oncology, urology, and immunology. Recently, the company has been active in advancing its pipeline and has made announcements regarding new clinical trials and partnerships. Investors can find the latest news, regulatory filings, and upcoming events related to Astellas Pharma on this page, providing valuable insights into its market position and strategic direction. The context of the pharmaceutical industry and ongoing developments may influence Astellas' performance and investor interest.

Research Astellas Pharma Inc.

Alternate listings